[NRIX] QoQ Quarter Result on 31-May-2023 [#Q2]

Stock
[NRIX] Nurix Therapeutics, Inc.
Announcement Date
13-Jul-2023
Financial Year
2023
Quarter
31-May-2023 [#Q2]
Profit Trend
QoQ- 38.33%
YoY- 51.67%
Quarter Report
NRIX's Result
NRIX's Financial Summary
View:
Show?
Quarter Result
29/02/24 30/11/23 31/08/23 31/05/23 28/02/23 30/11/22 31/08/22 CAGR
Revenue 16,585 15,159 18,467 30,676 12,685 6,783 10,791 33.21%
PBT -41,428 -41,956 -36,982 -24,277 -40,733 -46,717 -45,709 -6.35%
Tax 90 7,887 3,424 -2,488 -5,399 -5,010 -1,009 -
NP -41,518 -41,956 -36,982 -21,789 -35,334 -41,707 -44,700 -4.80%
Tax Rate - - - - - - - -
Total Cost 58,103 57,115 55,449 52,465 48,019 48,490 55,491 3.11%
Ratio Analysis
29/02/24 30/11/23 31/08/23 31/05/23 28/02/23 30/11/22 31/08/22 CAGR
NP Margin -250.33 -276.77 -200.26 -71.03 -278.55 -614.88 -414.23 -28.54%
Per Share
29/02/24 30/11/23 31/08/23 31/05/23 28/02/23 30/11/22 31/08/22 CAGR
EPS -0.76 -0.77 -0.68 -0.40 -0.65 -0.77 -0.88 -9.31%
EPS Diluted -0.76 -0.77 -0.68 -0.40 -0.65 -0.77 -0.88 -9.31%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.